| Title : Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial - Ueda_2018_Cardiovasc.Drugs.Ther_32_73 |
| Author(s) : Ueda S , Shimabukuro M , Arasaki O , Node K , Nomiyama T , Morimoto T |
| Ref : Cardiovasc Drugs Ther , 32 :73 , 2018 |
| Abstract : Ueda_2018_Cardiovasc.Drugs.Ther_32_73 |
| ESTHER : Ueda_2018_Cardiovasc.Drugs.Ther_32_73 |
| PubMedSearch : Ueda_2018_Cardiovasc.Drugs.Ther_32_73 |
| PubMedID: 29435776 |
Ueda S, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Morimoto T (2018)
Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial
Cardiovasc Drugs Ther
32 :73
Ueda S, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Morimoto T (2018)
Cardiovasc Drugs Ther
32 :73